Centaur Bio Inc. — Form D
Centaur Bio Inc. of CHARLOTTE, NC, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-27. The offering totals $500K, of which $430K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-04-27
- Form: D
- Accession: 0001975017-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $430K
- Remaining: $70K
- Minimum investment: $50K
- Investors: 4
- Date of first sale: 2023-04-06
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-480124
Issuer
- Name: Centaur Bio Inc.
- CIK: 0001975017
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 7805 PEMSWOOD STREET, CHARLOTTE, NC, 28277
- Phone: 704-807-6502
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Michael James Roberts | Executive Officer | Charlotte, NC |
Other filings by this issuer (3)
More